PTSD News

Parents of children with inflammatory bowel disease report relatively low rates of clinically significant psychological distress, even soon after their child’s IBD diagnosis, according to a cross-sectional study in Crohn’s & Colitis 360.

Apollo Neuroscience has announced the start of a clinical trial to provide insight into how its proprietary wearable touch therapy device impacts long-term outcomes following MDMA-assisted therapy in people with PTSD.

The University of Tennessee’s College of Nursing has been awarded a $3.7 million grant from HHS to provide mental health care services to rural communities with underrepresented and minority populations.

LOUISVILLE, Ky. — A speaker at the American Society for Preventive Cardiology Congress on CVD Prevention called on clinicians to have greater consideration for the effects of psychosocial factors on CVD and related outcomes.

McLean Hospital in Belmont, Massachusetts, has been named the top hospital in the United States for psychiatric care by the U.S. News & World Report for 2022 to 2023.

Forty-eight percent of American public health personnel reported at least one mental health issue, a small drop from 2021, according to survey responses published in MMWR.

The FDA has provided guidance to biopharmaceutical company Alzamend Neuro Inc. regarding its development of an oral therapeutic to treat a range of psychological disorders.

Researchers have described how to diagnose complex PTSD based on patient symptoms, following WHO’s new classification of the disorder, which differs from established PTSD.

Headache-related disability and PTSD symptom severity improved with cognitive behavioral therapy compared with usual care in United States military veterans with posttraumatic headache and PTSD, according to a study in JAMA Neurology.

PTSD was associated with accelerated decline in cognitive function in middle-aged women, researchers reported in JAMA Network Open.